Evidence map›Paper›PMID 25473218›Full record

ArticleAnnals of dermatology2014

Superoxide dismutase 1 inhibits alpha-melanocyte stimulating hormone and ultraviolet B-induced melanogenesis in murine skin.

Chang Taek Oh, Dohyun Lee, Kyotan Koo, Jay Lee, Ho Sang Yoon, Yoo Mi Choi, Tae-Rin Kwon, Beom Joon Kim

Open access · hybridAbstract read
In one paragraph

Article in Annals of dermatology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Chang Taek OhDepartment of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea. ; Department of Medicine, Graduate School, Chung-Ang University, Seoul, Korea.
Dohyun LeeNutrex Technology R&D Center, Seoul, Korea.
Kyotan KooNutrex Technology R&D Center, Seoul, Korea.
Jay LeeBiomedical Research Institute, MEDIPOST Co., Ltd., Seongnam, Korea.
Ho Sang YoonMB Business Development Team, Pacificpharma, Seoul, Korea.
Yoo Mi ChoiCosmeceutical Team, Pacificpharma, Seoul, Korea.
Tae-Rin KwonDepartment of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea. ; Department of Medicine, Graduate School, Chung-Ang University, Seoul, Korea.
Beom Joon KimDepartment of Dermatology, Chung-Ang University College of Medicine, Seoul, Korea. ; Department of Medicine, Graduate School, Chung-Ang University, Seoul, Korea.
Chung-Ang University · KRNexen (Canada) · CAPacific Environment · USMedipost (South Korea) · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver the last decade, the incidence of ultraviolet B (UVB)-related skin problems has increased. Oxidative stress caused by UVB induces the secretion of melanocyte growth and activating factors from keratinocytes, which results in the formation of cutaneous hyperpigmentation. Therefore, increasing the antioxidant abilities of skin cells is thought to be a beneficial strategy for the development of sunscreen agents. Superoxide dismutase 1 (SOD1) is an antioxidant enzyme that is known to exhibit antioxidant properties.

objectiveThe purpose of this study was to investigate the effect of SOD1 on alpha-melanocyte stimulating hormone (α-MSH) and UVB-induced melanogenesis in B16F10 melanoma cells and HRM-2 melanin-possessing hairless mice.

methodsThe inhibitory effect of SOD1 on tyrosinase activity was evaluated in a cell-free system. Additional experiments were performed using B16F10 melanoma cells to demonstrate the effects of SOD1 in vitro, and HRM-2 melanin-possessing hairless mice were used to evaluate the antimelanogenic effects of SOD1 in vivo.

resultsWe found that SOD1 inhibited melanin production in a dose-dependent manner without causing cytotoxicity in B16F10 melanoma cells. SOD1 did not inhibit tyrosinase activity under cell-free conditions. The results indicate that SOD1 may reduce pigmentation by an indirect, nonenzymatic mechanism. We also found that SOD1 decreased UVB-induced melanogenesis in HRM-2 melanin-possessing hairless mice, as visualized through hematoxylin and eosin staining and Fontana-Masson staining.

conclusionOur results indicate that SOD1 has an inhibitory effect on α-MSH and UVB-induced melanogenesis, indicating that SOD1 may be a promising sunscreen agent.

Indexed as

Alpha-MSHHRM-2Skin pigmentationSuperoxide dismutase 1Ultraviolet radiation

Identifiers

PMID25473218
PMCPMC4252663
OpenAlexW1988255391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.